Docetaxel plus gemcitabine versus gemcitabine in elderly patients with advanced non-small cell lung cancer and use of a geriatric assessment: Lessons from a prematurely closed Hellenic Oncology Research Group randomized phase III study
2017 ◽
Vol 8
(1)
◽
pp. 23-30
◽
Keyword(s):